NTRA
Price
$153.77
Change
-$0.71 (-0.46%)
Updated
Apr 25, 04:59 PM (EDT)
Capitalization
11.04B
9 days until earnings call
VCYT
Price
$32.23
Change
+$0.09 (+0.28%)
Updated
Apr 25 closing price
Capitalization
1.66B
9 days until earnings call
Ad is loading...

NTRA vs VCYT

Header iconNTRA vs VCYT Comparison
Open Charts NTRA vs VCYTBanner chart's image
Natera
Price$153.77
Change-$0.71 (-0.46%)
Volume$14.13K
Capitalization11.04B
Veracyte
Price$32.23
Change+$0.09 (+0.28%)
Volume$478.11K
Capitalization1.66B
NTRA vs VCYT Comparison Chart
Loading...
NTRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VCYT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NTRA vs. VCYT commentary
Apr 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NTRA is a Buy and VCYT is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 28, 2025
Stock price -- (NTRA: $154.48 vs. VCYT: $32.14)
Brand notoriety: NTRA and VCYT are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: NTRA: 43% vs. VCYT: 45%
Market capitalization -- NTRA: $11.04B vs. VCYT: $1.66B
NTRA [@Medical Specialties] is valued at $11.04B. VCYT’s [@Medical Specialties] market capitalization is $1.66B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NTRA’s FA Score shows that 1 FA rating(s) are green whileVCYT’s FA Score has 0 green FA rating(s).

  • NTRA’s FA Score: 1 green, 4 red.
  • VCYT’s FA Score: 0 green, 5 red.
According to our system of comparison, NTRA is a better buy in the long-term than VCYT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NTRA’s TA Score shows that 4 TA indicator(s) are bullish while VCYT’s TA Score has 3 bullish TA indicator(s).

  • NTRA’s TA Score: 4 bullish, 2 bearish.
  • VCYT’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, NTRA is a better buy in the short-term than VCYT.

Price Growth

NTRA (@Medical Specialties) experienced а +4.32% price change this week, while VCYT (@Medical Specialties) price change was +3.21% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +4.64%. For the same industry, the average monthly price growth was -4.89%, and the average quarterly price growth was -1.57%.

Reported Earning Dates

NTRA is expected to report earnings on Jul 31, 2025.

VCYT is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Medical Specialties (+4.64% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NTRA($11B) has a higher market cap than VCYT($1.66B). NTRA YTD gains are higher at: -2.413 vs. VCYT (-18.838). VCYT has higher annual earnings (EBITDA): -49.41M vs. NTRA (-397.8M). NTRA has more cash in the bank: 879M vs. VCYT (216M). VCYT has less debt than NTRA: VCYT (12.6M) vs NTRA (442M). NTRA has higher revenues than VCYT: NTRA (1.08B) vs VCYT (361M).
NTRAVCYTNTRA / VCYT
Capitalization11B1.66B661%
EBITDA-397.8M-49.41M805%
Gain YTD-2.413-18.83813%
P/E RatioN/AN/A-
Revenue1.08B361M300%
Total Cash879M216M407%
Total Debt442M12.6M3,508%
FUNDAMENTALS RATINGS
NTRA vs VCYT: Fundamental Ratings
NTRA
VCYT
OUTLOOK RATING
1..100
1466
VALUATION
overvalued / fair valued / undervalued
1..100
53
Fair valued
82
Overvalued
PROFIT vs RISK RATING
1..100
3083
SMR RATING
1..100
9488
PRICE GROWTH RATING
1..100
4555
P/E GROWTH RATING
1..100
10051
SEASONALITY SCORE
1..100
29n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NTRA's Valuation (53) in the Biotechnology industry is in the same range as VCYT (82). This means that NTRA’s stock grew similarly to VCYT’s over the last 12 months.

NTRA's Profit vs Risk Rating (30) in the Biotechnology industry is somewhat better than the same rating for VCYT (83). This means that NTRA’s stock grew somewhat faster than VCYT’s over the last 12 months.

VCYT's SMR Rating (88) in the Biotechnology industry is in the same range as NTRA (94). This means that VCYT’s stock grew similarly to NTRA’s over the last 12 months.

NTRA's Price Growth Rating (45) in the Biotechnology industry is in the same range as VCYT (55). This means that NTRA’s stock grew similarly to VCYT’s over the last 12 months.

VCYT's P/E Growth Rating (51) in the Biotechnology industry is somewhat better than the same rating for NTRA (100). This means that VCYT’s stock grew somewhat faster than NTRA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NTRAVCYT
RSI
ODDS (%)
N/A
Bullish Trend 6 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 6 days ago
76%
Bearish Trend 6 days ago
89%
Momentum
ODDS (%)
Bullish Trend 6 days ago
76%
Bullish Trend 6 days ago
82%
MACD
ODDS (%)
Bullish Trend 6 days ago
88%
N/A
TrendWeek
ODDS (%)
Bearish Trend 6 days ago
77%
Bearish Trend 6 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 6 days ago
77%
Bearish Trend 6 days ago
83%
Advances
ODDS (%)
Bullish Trend 13 days ago
82%
Bullish Trend 14 days ago
76%
Declines
ODDS (%)
Bearish Trend 7 days ago
80%
Bearish Trend 7 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 6 days ago
90%
Bearish Trend 6 days ago
82%
Aroon
ODDS (%)
N/A
Bearish Trend 6 days ago
83%
View a ticker or compare two or three
Ad is loading...
NTRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VCYT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA259.518.77
+3.50%
Tesla
SPY546.6911.27
+2.10%
SPDR® S&P 500® ETF
AAPL208.373.77
+1.84%
Apple
BTC.X93943.800000244.687500
+0.26%
Bitcoin cryptocurrency
GME27.08-0.04
-0.15%
GameStop Corp

NTRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, NTRA has been loosely correlated with ISRG. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if NTRA jumps, then ISRG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NTRA
1D Price
Change %
NTRA100%
+3.98%
ISRG - NTRA
55%
Loosely correlated
+4.14%
GH - NTRA
50%
Loosely correlated
+3.88%
GKOS - NTRA
49%
Loosely correlated
+3.05%
RDNT - NTRA
49%
Loosely correlated
+2.94%
VCYT - NTRA
49%
Loosely correlated
+2.15%
More

VCYT and

Correlation & Price change

A.I.dvisor indicates that over the last year, VCYT has been loosely correlated with GH. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if VCYT jumps, then GH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VCYT
1D Price
Change %
VCYT100%
+2.15%
GH - VCYT
51%
Loosely correlated
+3.88%
NTRA - VCYT
48%
Loosely correlated
+3.98%
TWST - VCYT
48%
Loosely correlated
+6.78%
INGN - VCYT
46%
Loosely correlated
+3.92%
ILMN - VCYT
46%
Loosely correlated
+1.78%
More